Drawing for GENEMATCH

USPTO serial 87004286

GENEMATCH

Reviewed by CopyMark Law Group

Reg. 5047271Status 701Renewal
Filing date
Status date
Registration date
Sep 20, 2016
Examiner
GALAN, MATTHEW
Law office
TMO LAW OFFICE 113

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with GENEMATCH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $1,700

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rachel A. Nicholas

Rachel A. Nicholas Womble Bond Dickinson (US) LLP201 East Washington Street, Suite 1200Phoenix, AZ 85004United States

Goods and services

ClassDescriptionStatusFirst use
042Medical and scientific research services related to the treatment and prevention of Alzheimer's disease; providing medical testing services in the field of Alzheimer's disease for research purposes; conducting research and clinical trials relating to the treatment and prevention of Alzheimer's diseaseACTIVEDec 8, 2015
044Providing medical testing services for diagnostic or treatment purposes and medical information in the field of Alzheimer's diseaseACTIVEDec 8, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 16, 2026E89RTEAS SECTION 8 & 9 RECEIVED—
Sep 20, 2025REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
May 20, 2023NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
May 20, 20238.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
May 20, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 14, 2022ES8RTEAS SECTION 8 RECEIVED—
Sep 20, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 14, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 14, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 14, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 14, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 14, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 20, 2016R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Aug 18, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 10, 2016ALIEASSIGNED TO LIE—
Jul 28, 2016CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Jul 28, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Jul 28, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 28, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 28, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 26, 2016DOCKASSIGNED TO EXAMINER—
Apr 22, 2016MPMKNOTICE OF PSEUDO MARK E-MAILED—
Apr 21, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 21, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance